Ensysce Biosciences
ENSC
9 hedge funds and large institutions have $714K invested in Ensysce Biosciences in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
592% more capital invested
Capital invested by funds: $103K → $714K (+$611K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
13% more funds holding
Funds holding: 8 → 9 (+1)
2.03% more ownership
Funds ownership: 0.02% → 2.05% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$972K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$109K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$52.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$65K |
| 2 |
PIA
Powell Investment Advisors
Miami,
Florida
|
-$16.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$12.4K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$1.69K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $580K | +$972K | +21,487 | New |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $65.3K | +$109K | +2,417 | New |
|
|
GCP
3
GSA Capital Partners
London,
United Kingdom
| $32K | +$52.9K | +1,170 | New |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $27.8K | +$46.5K | +1,028 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $7.02K | +$9.77K | +216 | +491% |
|
6
BlackRock
New York
| $1.75K | – | – | – |
|
|
PMFA
7
Plante Moran Financial Advisors
Southfield,
Michigan
| $36 | – | – | – |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| $21 | – | – | – |
|
9
Wells Fargo
San Francisco,
California
| $18 | +$45 | +1 | New |
|
|
VF
10
Virtu Financial
New York
| – | -$65K | -896 | Closed |
|
|
PIA
11
Powell Investment Advisors
Miami,
Florida
| – | -$16.2K | -222 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$12.4K | -170 | Closed |
|
|
ASN
13
Advisory Services Network
Atlanta,
Georgia
| – | -$1.69K | -23 | Closed |
|
ENSC Hedge Fund Activity: Q2 2023 in Review
9 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q2 2023, worth a combined $714K — up 592% from $103K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ENSC positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $972K. The largest seller was Virtu Financial, exiting entirely with an estimated $65K sold.
- 9 institutional investors held Ensysce Biosciences (ENSC) as of Q2 2023, up from 8 in Q1 2023.
- Funds reported $714K of Ensysce Biosciences stock for Q2 2023, up 592% quarter-over-quarter.
- 5 funds opened new Ensysce Biosciences positions in Q2 2023 and 4 closed out, a net change of +1 holder.
- The largest Ensysce Biosciences buyer in Q2 2023 was Sabby Management, an estimated $972K added.
- The largest Ensysce Biosciences seller in Q2 2023 was Virtu Financial, an estimated $65K sold.
Based on aggregated 13F filings for Q2 2023.